The Prevalence and Risk Factors of Hepatitis B Virus Infection in an Adult Population in Romania: a Nationwide Survey
Overview
Affiliations
Aim: The prevalence and risk factors of hepatitis B virus (HBV) infection in the general population in Romania are still largely unknown.
Methods: A nationwide cross-sectional survey among a Romanian adult population (18-69 years) was conducted during 2006-2008 using a stratified, multistage sampling design. A total of 17 600 individuals were enrolled randomly into the study; the prevalence of chronic HBV infection (HBsAg-positive and anti-HBcAb-positive samples) was assessed on 13 127 individuals (74.6%) and a history of previous HBV infection (anti-HBcAb-positive, but HBsAg-negative samples) was assessed on 12 470 individuals (70.5%). A questionnaire was used to collect information on the sociodemographic characteristics of the participants and the potential risk factors for HBV transmission.
Results: The overall prevalence rate of HBV chronic infection among all the participants tested was 4.4% (confidence interval: 4.0-4.8%), with significant differences (P=0.0001) between participants from the main geographical regions of residence (Moldavia 4.5%, Muntenia and Dobrogea 5.4%, and Transylvania and Banat 3.1%). The total prevalence of previous HBV infection of all participants was 27.0% (confidence interval: 26.2-27.8%). The proportion of individuals with previous HBV infection, as well as with chronic HBV infection, showed a statistically significant increasing trend with age. The personal history of blood or blood product transfusion, surgical interventions, tattooing, and alcohol consumption greater than 60 g/day were risk factors associated with both anti-HBcAb and HBsAg seropositivity.
Conclusion: A prevalence rate of 4.4 and 27.0% for HBsAg and anti-HBcAb, respectively, represents a high figure within the European Union and a strong motivation for developing adequate strategies for prevention, active detection, and treatment of HBV infection in Romania.
Zoa-Assoumou S, Mboyis-Kamdem H, Mougola-Bissiengou P, Nzengui-Nzengui G, Kombila-Koumavor C, Mbani-Okouma M IJID Reg. 2025; 13:100448.
PMID: 39885836 PMC: 11780383. DOI: 10.1016/j.ijregi.2024.100448.
Curici A, Ilie O, Mindru D Microorganisms. 2025; 13(1).
PMID: 39858886 PMC: 11768068. DOI: 10.3390/microorganisms13010118.
Lamichhane R, Adhikari P, Pathak B, Rai A, Ojha P, Maharjan K PLoS One. 2024; 19(11):e0310443.
PMID: 39585861 PMC: 11588231. DOI: 10.1371/journal.pone.0310443.
Iacob S, Csiki I, Iacob R, Ghioca M, Constantinescu I, Chiper B Viruses. 2024; 16(8).
PMID: 39205292 PMC: 11360111. DOI: 10.3390/v16081318.
Tesfaye S, Alemu A, Bizualem E, Mehabie D, Alelign A SAGE Open Med. 2024; 12:20503121241266347.
PMID: 39092161 PMC: 11292706. DOI: 10.1177/20503121241266347.